Renal cell carcinoma of the clear cell type (ccRCC) is associated with loss of functional von Hippel-Lindau (VHL) protein and high, homogeneous expression of the G250 MN protein, an isoenzyme of the carbonic anhydrase family. High expression of G250
Introduction

G250
MN , a member of the carbonic anhydrase family (Opavsky et al., 1996) , has been implicated as a possible marker for hypoxia in various tumors (Loncaster et al., 2001; Kaanders et al., 2002) . Heterogeneous G250 MN expression has been shown in various tumor types with absence of G250 MN expression in the corresponding normal tissue. Although G250 MN expression correlates with lowered O 2 tension to a certain extent, G250 MN expression can be observed beyond hypoxic regions, possibly representing areas that were hypoxic before (Kaanders et al., 2002) . Additionally, G250
MN expression was correlated with a more favorable disease progression of patients with advanced renal cell carcinoma (RCC) (Bui et al., 2003) , and G250 MN expression may be involved in oncogenesis and tumor progression of non-RCC tumors (Beasley et al., 2001; Ivanov et al., 2001) . Immunohistochemical studies of RCC demonstrated high, homogeneous G250
MN expression in clear cell RCC (ccRCC) (Oosterwijk et al., 1986; Uemura et al., 1999) , suggesting that critical elements promoting G250 expression are constitutively present/active in this tumor.
Somatic inactivation of the von Hippel-Lindau (VHL) gene is common in sporadic ccRCC and is considered an important initiating event (Martinez et al., 2000; Mandriota et al., 2002) . The VHL protein functions as the recognition element of a multiprotein E3 ubiquitin ligase complex, involved in rapid degradation of hypoxia-inducible factors (HIFs) under physiological oxygen conditions (normoxia) (Maxwell et al., 1999) . In ccRCC lacking functional VHL, HIF units accumulate under normoxic conditions directing the expression of genes otherwise only expressed under hypoxic conditions. The involvement of transcription factors (TFs) HIF-1 and HIF-2 in G250 MN transcription has been recognized (Wykoff et al., 2000) , but in other studies overexpression of HIF-1a could not be detected in a substantial subpopulation of RCC (Wiesener et al., 2001) , suggestive of other control elements in CAIX promoter activation. Finally, recent studies imply cell type-specific HIF-1/2a usage (Elvert et al., 2003) , which may play a role in specific CAIX gene activation. Nevertheless, G250
MN activation was regarded one of the most appropriate HIF target genes to identify early foci of VHL inactivation . CAIX promoter studies have established the involvement of HIF, and several critical promoter regions have been identified in HeLa cells, harboring AP1-and Sp1-binding sites (Kaluz et al., 1999; Kaluzova et al., 2001) . The Sp1/HRE (HRE: hypoxia-responsive element) containing portion of the CAIX promoter has been suggested as a novel type of HRE (Kaluz et al., 2003) . Clearly, the situation in ccRCC is entirely different and the precise role of Sp1, AP1 and HIF factors in the cooperative activation of the CAIX promoter in ccRCC remains unclear. To further understand the TF complex governing CAIX promoter activation in ccRCC, we performed a detailed analysis of the CAIX promoter in RCC cells.
Results
Structure of the 5
0 -flanking region of the human CAIX
G250 gene
A genomic clone (lFIX-EO6) containing the 5 0 end of the human CAIX gene was identified by screening a human genomic library and subcloned in plasmid vectors for DNA sequence analysis. One plasmid containing exon 1 of the CAIX gene and 1.3 kb (position À1258/ þ 260) of 5 0 -flanking sequences was identified ( Figure 1a ) and the nucleotide sequence of the 5 0 -flanking region was determined (Figure 1b) .
Identification of potential TF-binding sites by the TESS software on the WWW, using the TRANSFAC 4.0 matrices, revealed no canonical binding sites at consensus positions, including initiator element and TATA box. However, several potential TF-binding sites could be identified in the proximal promoter region (Figure 1b) , including Sp1 and AP elements and one HRE, in agreement with earlier studies (Kaluz et al., 1999) .
Transcriptional activity of the human CAIX G250 promoter
Transient transfection of a 1.1. kb fragment containing the putative CAIX promoter (position À1070/ þ 31) into RCC cell lines led to strong promoter activity (0.9-and 4-fold of the herpes simplex virus-thymidine kinase (HSV-tk) promoter, respectively) in the G250-positive RCC cell lines, whereas no CAIX promoter activity was observed in G250-negative RCC cell lines. A construct Transfection of deletion constructs resulted in an increased promoter activity (constructs À479/ þ 31, À189/ þ 31 and À116/ þ 31), compared to the 1.1 kb construct (Figure 2b ). Further truncation resulted in a significant decrease in promoter activity, although construct À60/ þ 31 still showed significant promoter activity (0.6-fold of HSV-tk). None of the constructs tested showed promoter activity in the G250-negative RCC cell lines (Figure 2b) .
Base substitution mutants were created in the À116/ þ 31 construct to investigate the importance of potential TF-binding sites within the proximal CAIX promoter (Figure 2c) . Mutations in the AP-1 (position À111) and Sp1 (position À61/À62) elements or both resulted in a 50% decrease in CAIX promoter activity when compared to the wild-type reporter construct ( Figure 2c ). Base substitutions in the Sp1 element at position À41 to À50, overlapping with a functional AP-2 site, shown to bind AP-2 (Kaluz et al., 1999) , almost completely abolished promoter activity (495% reduction). Mutation of this AP-2 site, leaving the Sp1 site intact, did not affect CAIX promoter activity. Finally, mutations in the HRE sequence motif (position À13/À18) also reduced promoter activity of the À116/ þ 31 construct by more than 95%.
Protein-DNA interaction at the most proximal Sp1 binding site and at the HRE DNase-I footprint analysis of the functionally important Sp1 element in the CAIX promoter showed protection of two regions: À37 to À60 (Figure 3a ) corresponding to the predicted Sp1 binding sequence and region À115 to À145 (Figure 3a ) covering the Sp1 site at position À136 to À145, exceeding to the AP-1 site at position À107 to À114. Three sequence-specific protein-DNA complexes were observed in G250-positive and G250-negative RCC cells with construct À60/ þ 31. Addition of an Sp1-specific antibody resulted in a supershift of one of the protein-DNA complexes formed ( Figure 3b ).
EMSA analysis with an oligonucleotide containing the G250 HRE (position À13 to À18) and NEs from SKRC-7 cells demonstrated the formation of three sequence-specific protein-DNA complexes ( Figure 4a No specific protein-DNA interactions could be detected, nor competition could be achieved when the HRE oligonucleotide containing the HIF binding site mutations (see Figure 2c ) was used as probe or competitor in EMSA (data not shown).
HIF-1a expression and DNA binding determine G250 expression
Western blot analyses showed that G250 expression was coupled to HIF-1a protein expression, and vice versa (Figure 4b ). In addition, all cell lines that expressed HIF-1a at the protein level showed HIF-1a binding to the CAIX HRE in vitro (Figure 4c ). The cell line SKRC-52 expressed a truncated HIF-1a protein encoded by an alternatively spliced transcript (Gothie et al., 2000) ( Figure 4b , indicated by an asterisk), which showed an altered mobility in the EMSA, but apparently is functional in activating CAIX expression. In contrast to the differential expression of HIF-1a and its binding to Since VHL inactivation has been tightly linked to HIF-a protein stabilization, the VHL status in G250-positive and -negative SKRC cell lines was determined (Table 1) . SSCP analysis showed that G250-positive and G250-negative RCC cell lines contained mutated VHL genes. In these cell lines, no wild-type allele could be detected by DNA sequence analysis, indicating mutation and/or loss of both wild-type alleles.
Methylation-specific PCR showed that SKRC-10 contained a methylated VHL gene promoter region, resulting in undetectable VHL mRNA expression (data not shown). Thus, although all cell lines showed loss of wild-type VHL expression, not all cell lines express HIF1a and G250 MN .
Involvement of cofactor CBP/p300 in G250 transcription
Cotransfection of an E1A-encoding construct able to bind the cofactor CBP/p300, known to bind independently to both Sp1 and HIF, with the CAIX promoter construct À116/ þ 31 into SKRC-10 cells resulted in a reduction of CAIX promoter activity to about 25% of mock-transfected cells (Figure 5a ). Cotransfection with mutant E1ADp300 unable to bind CBP/p300 did not significantly alter CAIX promoter activity, whereas cotransfection with mutant E1ADRb, deficient in Rb binding, but able to bind CBP/p300, also reduced CAIX promoter activity to about 25%. E1A gene expression of primary kidney epithelial cell cultures was established by infection with wild-type adenovirus. Hypoxia by CoCl 2 treatment of adenovirusinfected cells showed a more than 50% reduction of CAIX mRNA compared to uninfected cells (Figure 5b and data not shown). CAIX expression was similar to uninfected cells when an E1A-ablated adenovirus was used in combination with CoCl 2 .
Discussion
In the present study, the transcriptional regulation of the gene encoding for G250 MN in ccRCC was examined. Previous studies have concentrated on CAIX G250 gene regulation in non-RCC settings, demonstrating the importance of Sp1/Sp3 and HRE regulatory elements. This study demonstrates the critical importance of HIF1a and Sp1 for CAIX activation in RCC, and identifies CBP/p300 as a crucial coactivator. CAIX expression appeared to be completely dependent on HIF-1a: CAIX expression was only observed in HIF-1a-positive conditions, whereas HIF-2a expression in the absence of (Motzer et al., 1996) . Although HIF-1a and HIF-2a are structurally similar in their DNA binding and dimerization domains, they differ in their transactivation domains, implying they may have unique target genes. Indeed, this study demonstrates that CAIX is uniquely regulated by HIF1a, that is, that HIF-1a and HIF-2a have unique targets. This extends the results of Hu et al. (2003) , who showed that HIF-1a (and not HIF-2a) stimulated glycolytic gene expression, demonstrating that HIF-1a and HIF-2a can regulate unique targets. Apparently, CAIX is another gene member belonging to a family of strictly HIF-1a-regulated genes. The reverse, strict dependency on HIF2a not HIF-1a, was observed for VEGF-2, another gene expressed under hypoxic conditions (Elvert et al., 2003) .
In accordance with studies in non-RCC cells, the minimal promoter region of the CAIX gene contained a putative HIF binding element and several AP-1/2 and Sp1 binding elements that have been indicated as pivotal for CAIX expression by circumstantial evidence. Mutation of the HIF and the most proximal Sp1 elements led to a dramatic decrease in promoter activity in RCC cells, demonstrating their functional importance. Sequestration of CBP/p300 (cAMP responsive element binding factor (CREB)-binding protein), a common coactivator that can independently bind Sp1 as well as HIF (Arany et al., 1996; Liu and Simpson, 1999; Suzuki et al., 2000) , by E1A constructs able to bind CBP/p300 led to a substantial decrease of CAIX promoter activation, showing that CBP/p300 is involved in the transcription of G250 in RCC. Under normoxic conditions such as in ccRCC cells, the cooperation between Sp1 and HIF may be required for efficient tethering of CBP/p300, because hydroxylation of a critical asparagine residue in HIF-1a may impede the recruitment of CBP/p300 independently of other TFs (Sang et al., 2002) despite the presence of high HIF levels. Alternatively, another cofactor(s), such as SRC-1/p165, may be involved in CAIX promoter regulation that may compete or cooperate with the cofactor CBP/p300 (Carrero et al., 2000) .
Sp1 binding has been proposed to provide a platform for an inducible factor X in CAIX activation, regulated by a combination of cell-density-induced PI3-K activation and lowered oxygen tension (Kaluz et al., 2003) . It is unlikely that this proposed inducible factor X plays a role in CAIX expression in ccRCC, since cell density does not influence CAIX expression in ccRCC. Consequently, it is unlikely that CBP/p300 is the proposed factor X.
In RCC cell lines, HIF-1a was clearly crucial for CAIX activation. Nevertheless, a substantial number of ccRCC do not show VHL aberrations. Mutations in VHL-associated proteins leading to accumulation of HIF-1a could then explain G250 MN expression in ccRCC despite the presence of wild-type VHL. However, such inactivating mutations of elongin B and C, Cul2 and Rbx1 in ccRCC cells could not be detected (Clifford et al., 2001) . Additionally, HIF-1a stabilization cannot be detected in a substantial percentage of ccRCC. However, virtually all ccRCC express G250 MN . In vitro experiments with hypoxic normal kidney epithelial cells led to enhanced G250 MN expression, suggesting that additional (unidentified) VHL/HIF-1a-associated factors, possibly including a kidney-specific TF, can function in CAIX regulation. This situation is comparable to the promoter of the stem cell leukemia gene that is also regulated by tissue-specific as well as general TFs (Bockamp et al., 1998) . Alternatively, the recently described antisense HIF-1a transcript (aHIF) highly expressed in ccRCC may be of importance, but its role remains to be established (Thrash-Bingham and Tartof, 1999) . Finally, our observations cast doubts on the assumption that CAIX can be regarded as a surrogate marker of VHL inactivation .
Repressor binding, as observed in non-RCC cells (Kaluz et al., 1999) was not found (data not shown), suggesting that in RCC this repressor protein is absent or does not affect CAIX expression. Additionally, in non-RCC, deletion of regions À55/À34 or À81/À66 decreased promoter activity approximately fivefold, whereas deletion of À60/À33 abolished CAIX promoter activity completely in RCC. Finally, Kaluz et al. showed that AP2 is one of the transactivators binding to À55/À34. However, multiple complexes bind to À55/À34 as shown by EMSA. Our results suggest that binding Figure 5 CBP/p300 involvement in CAIX G250 promoter activity. (a) CAIX promoter activity (construct À116/ þ 31) after cotransfection with the indicated E1A constructs was determined as described in Figure 2 and normalized to HSV-tk promoter activity. (b) CAIX G250 -specific RT-PCR on primary kidney epithelial cell cultures infected with wild-type adenovirus (serotype 5) or with an E1-deleted replication-deficient Ad5 virus (MOI ¼ 1.0). M, marker; 1 and 2, uninfected cells; 3, wild-type Ad5 infected; 4, E1-deleted Ad5; and 5, negative control; cultures # 2-4 were treated with 200 mM CoCl 2 . b-2-Microglobulin (b2M) was used as a control for the quality of cDNA synthesis ccRCC-specific CAIX G250/MN gene regulation K Grabmaier et al of transactivator Sp1 and not AP-2 to this region determines promoter activity in ccRCC cells. Most likely, AP1 cannot tether CBP/p300 in combination with HIF-1a, thereby failing to activate CAIX gene expression. Alternatively, the requirement of CBP/p300 is cell type specific as recently suggested (Hu et al., 2003) . It is quite possible that CAIX is activated by HIF-1a, AP1 and another transactivating factor in non-RCC. RCC of the clear cell type is associated with loss of functional VHL gene product leading to stabilization of HIFa proteins, and with expression of the G250 MN protein. We identified the region À60/ þ 31 as the CAIX G250 minimal promoter region and show that binding of the TFs HIF-1a and Sp1 to this region of the CAIX promoter is indispensable for its activity in RCC. In addition, we show that it is likely that under normoxic conditions the cofactor CBP/p300 is recruited by HIF-1a and Sp1 and that CBP/p300 is a major determinant of CAIX promoter activity. This adds CAIX to the list of genes strictly regulated by HIF-1a, at least in ccRCC.
Materials and methods
Isolation of the CAIX promoter
G250 genomic sequences were isolated from a lFIXII human placenta genomic DNA library (Stratagene) as described (Grabmaier et al., 2000) . A G250 cDNA fragment (pMW3, base pairs 23-256) was used as probe for the hybridizations. DNA was isolated from phage EO6 (Sambrook and Russell, 2001) , and subcloned in pBluescript or pUC18 plasmid vectors. Plasmid DNA was isolated by standard procedures (Sambrook and Russell, 2001 ) and sequenced using vectorspecific primers, the ABI PRISM BigDye Terminator Cycle Sequencing kit (PE-Biosystems) and an automated DNA analyser (ABI PRISM 3700, PE-Biosystems).
Promoter-reporter plasmid construction A 1.1. kb fragment of pEO6.5.1 (À1068/ þ 31) was cloned into the promoter-less reporter plasmid p0GH (Nichols Diagnostics Institute). Truncation of the reporter plasmid was performed by polymerase chain reaction (PCR) amplification of the regions of interest using pEO6.5.1 as a template and the following HincII-tagged forward primers and an XbaI-tagged reverse primer (tags not shown):
. PCR products were digested with HincII/XbaI, gel-purified and cloned into the HincII/XbaI sites of p0GH.
Site-directed mutagenesis was performed using the GeneEditor in vitro site-directed mutagenesis system, according to the manufacturer's instructions (Promega). The 'mutagenic' oligonucleotides used were as follows: in forward orientation 5 0 -AACCTGTGACACTTTGGC-3 0 (mutation of the AP1 site at position À111) and 5 0 -GTCAGCCTGCTCAACTCCAG-GCTTGC-3 0 (Sp1 site at position À62/À61), and in reverse orientation 5 0 -GGAAACGAGAGCTGGGTGGGTGATTAG-CAAGCCTGG-3 0 (Sp1 site at position À47/À46/À43), 5 0 -GGAAACGAGAGCTTGGTGGGGGAGGAGCAAGC-CTGG-3 0 (AP2 site at position À36), 5 0 -GGAAACGA-GAGCCGGGTGGGGTATTAGCAAGCCTGG-3 0 (Sp1 and AP2 sites) and 5 0 -TACGGGCTGTACCAGCATTGGAA-ACG-3 0 (HRE at position À17/À16). Adenovirus E1A gene constructs were kindly provided by Dr A Zantema (Molecular Cell Biology, LUMC, Leiden, The Netherlands).
Cell culture and adenovirus infection
Human SKRC cell lines have been described previously (Ebert et al., 1990) . Primary cultures of normal kidney epithelium were grown from biopsy specimens taken at nephrectomy. All cells were grown in RPMI 1640 medium, supplemented with 10% fetal calf serum (Gibco), in an atmosphere of 5% CO 2 and 371C.
Primary kidney epithelial cultures were infected with wildtype or replication-deficient adenovirus (serotype 5) (kindly provided by Dr RA Willemsen, Erasmus UMC, The Netherlands) at a multiplicity of infection (MOI) of 1.0. At 3 days post infection, total RNA was isolated from the cultures using Trizol (Life Technologies) and analysed by G250-specific RT-PCR.
Transient transfection assays
RCC cells were transfected with 3 mg of G250-hGH (hGH: human growth hormone), 2.3 mg of pCMV-110 encoding bgalactosidase to be able to correct for transfection efficiency with or without E1A-encoding constructs using Fugene-6 according to the manufacturer's instructions (Roche Diagnostics). All transfections were performed at least three times in duplicate. Cells and medium were harvested 72 h after transfection and stored at À201C until use.
hGH secretion was determined by the Delfia hGH assay kit (Wallac Oy, Turku, Finland), according to the manufacturer's instructions. The pTKGH plasmid (Nichols Diagnostics Institute) was used as positive control. hGH values and relative induction values are expressed as mean and standard error of the mean.
DNase-I footprint analysis
One strand end-labeled DNA probes were generated by labeling the 5 0 end of CAIX promoter-specific primers with [g-32 P]ATP (B3000 Ci/mmol, Amersham), followed by PCR amplification of DNA fragments with one labeled and one unlabeled primer and purification from 5% polyacrylamide gels (Sambrook and Russell, 2001 ). For each DNase-I footprint reaction, 1.5-3.0 fpu recombinant Sp1 protein (Promega) was used as described (Verhaegh et al., 2000) .
Electrophoretic mobility shift assay (EMSA)
Primers for PCR amplification of CAIX promoter fragment À60/ þ 31 and a double-stranded oligonucleotide, containing base pairs À8 to À27 of the CAIX promoter, were end-labeled with [g-32 P]ATP (B3000 Ci/mmol, Amersham). DNA probes (0.5 ng) were incubated with nuclear extract (NE, 15 mg), and separated on 4% polyacrylamide gels as described (Verhaegh et al., 2000) . For supershift assays, antibodies against Sp1 (4 mg, Santa Cruz), HIF-1a (2 mg, Santa Cruz), HIF-2a (6.3 mg, Novus Biologicals) or IgG control were added to the binding reactions.
VHL mutation (SSCP) and methylation analysis (PCR)
SSCP analysis was performed as described (Vet et al., 1998) . VHL gene mutations were confirmed by DNA sequence analysis. VHL promoter methylation was determined by PCR using methylation-specific PCR primers, as described (Herman et al., 1994) .
Western blot analysis
Whole-cell extracts were prepared and analysed by Western blot as described (Michel et al., 2002) with the following modifications: The cell lysis buffer used contained 20 mM Tris-HCl (pH 7.5), 150 mM NaCl 2 , 5mM EDTA, 1% Triton X-100 and Complete s protease inhibitor cocktail (Boehringer Roche). Blots were hybridized with antibodies against G250 (clone M75, 1 : 25) (Loncaster et al., 2001) , HIF-1a (0.83 mg/ml, BD Biosciences), HIF-2a (5.4 mg/ml, ab199, Abcam) or a-tubulin (0.4 mg/ml, Molecular Probes).
Abbreviations CAIX, G250 gene; ccRCC, clear cell renal cell carcinoma; EMSA, electrophoretic mobility shift assay; G250, G250 CAIX/ MN ; HIF, hypoxia-inducible factor; HGH, human growth hormone; HRE, hypoxia-responsive element; HSV-tk, herpes simplex virus-thymidine kinase; NE, nuclear extract; PCR, polymerase chain reaction; TF, transcription factor; VHL, von Hippel-Lindau.
